Subscribe
Share
Share
Embed
Linda Hasadsri, M.D., Ph.D., discusses Mayo Clinic Laboratories' comprehensive approach to testing for mitochondrial disease, a challenging condition to diagnose because of the extreme variance in disease presentation. Mayo Clinic Laboratories’ suite of biochemical and molecular mitochondrial disease tests employs emerging technologies, including next generation sequencing and droplet digital PCR, to identify genetic biomarkers and mutations, confirm diagnosis, and determine heteroplasmy.
A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.